Whole-body Tc-99m sestamibi scintigraphy in the follow-up of differentiated thyroid carcinoma

Clinical Nuclear Medicine

Volumn 25, Issue 6, 2000, Pages 443-446

  Almeida Filho, Paulo ^a   Ravizzini, Gregory C ^b   Almeida, Cristiana ^a   Borges Neto, Salvador ^b  

^a FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Iodine 131; Tc 99m Sestamibi; Thyroglobulin; Thyroid Carcinoma

Indexed keywords

IODINE 131; LEVOTHYROXINE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; THYROGLOBULIN; THYROGLOBULIN ANTIBODY;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; THORAX RADIOGRAPHY; THYROGLOBULIN BLOOD LEVEL; THYROID CARCINOMA; THYROIDECTOMY; TREATMENT PLANNING; TUMOR DIFFERENTIATION; WHOLE BODY SCINTISCANNING;

ADENOCARCINOMA, FOLLICULAR; ADULT; CARCINOMA; CARCINOMA, PAPILLARY; FEMALE; FOLLOW-UP STUDIES; HUMANS; IODINE RADIOISOTOPES; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; NEOPLASM RECURRENCE, LOCAL; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M SESTAMIBI; THYROGLOBULIN; THYROID NEOPLASMS; THYROIDECTOMY; THYROXINE; TUMOR MARKERS, BIOLOGICAL; WHOLE-BODY IRRADIATION;

EID: 0034040315     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003072-200006000-00011     Document Type: Article

References (26)

1. Hoefnagel CA, Delprat CC, Marcuse HR, de Vijlder JJM: Role of thallium-201 total-body scintigraphy in follow-up of thyroid carcinoma. J Nucl Med 27:1854, 1986.
2. Dadparvar S, Chevres A, Tulchinsky M, et al: Clinical utility of technetium-99m methoxyisobutylisonitrile imaging in differentiated thyroid carcinoma: Comparison with thallium-201 and iodine-131 Na scintigraphy, and serum thyroglobulin quantitation Eur J Nucl Med 22:1330, 1995.
3. Hisada K, Tonami N, Miaymae T, et al: Clinical evaluation of tumor imaging with 201 TI chloride. Radiology 129:497, 1978.
4. Ancri D, Basset JY, Lonchampt MF, Etavard C: Diagnosis of cerebral lesions by thallium-201. Radiology 128:417, 1978.
5. Tonami N, Hisada K: Thallium-201 scintigraphy in postoperative detection of thyroid cancer. Radiology 136:461, 1980.
6. Nemec J, Zamrazil V, Pohunkova D, Rohling S, Holub V: The rational use of 201Tl scintigraphy in the evaluation of differentiated thyroid cancer. Eur J Nucl Med 9:261, 1984.
7. Cosimelli M, Schillaci A, Benaglia A, et al: Diagnosing metastases of differentiated thyroid carcinoma with thallium scan: A case report. Clin Oncol 10:163, 1984.
8. Hassan IM, Sahweil A, Constantinidis C, et al: Uptake and Kinetics of Tc-99m-hexakis 2-methoxy: Isobutyl isonitrile in benign and malignant lesions in the lungs. Clin Nucl Med 14:333, 1989.
9. O'Driscoll CM, Baker F, Casey MJ, Duffy GJ: Localization of recurrent medullary thyroid carcinoma with technetium-99m-methoxyisobutylisonitrile scintigraphy: A case report. J Nucl Med 32:2281, 1991.
10. O'Doherty MJ, Kettle AG, Well P, Collins REC, Coakley AJ: Parathyroid imaging with technetium-99m-sestamibi: Preoperative localization and tissue uptake studies. J Nucl Med 33:313, 1992.
11. Taillefer R, Boucher Y, Potvin C, Lambert R: Detection and localization of parathyroid adenomas in patients with hyperparathyroidism using a single radionuclide imaging procedure with technetium-99m-sestamibi (double-phase study). J Nucl Med 33:1801, 1992.
12. Caner B, Kitapci M, Unlu M, et al: Technetium-99m-MIBI uptake in benign and malignant bone lesions: A comparative study with technetium-99m-MDP. J Nucl Med 33:319, 1992.
13. Scott AM, Kostakoglu L, O'Brien JP, et al: Comparison of technetium-99m-MIBI and thallium-201-chloride uptake in primary thyroid lymphoma. J Nucl Med 33:1396, 1992.
14. LeBouthillier G, Morais J, Picard M, et al: Tc-99m sestamibi and other agents in the detection of metastatic medullary carcinoma of the thyroid. Nucl Med 18:657, 1993.
15. Kao CH, Wang SJ, Lin WK, et al: Differentiation of single solid lesions in the lungs by means of single-photon emission tomography with technetium-99m methoxyisobutylisonitrile. Eur J Nucl Med 20:249, 1993.
16. O'Tuama LA, Treves ST, Lanar JN, et al: Thallium-201 technetium-99m-MIBI SPECT in evaluation of childhood brain tumors: A within-subject comparison. J Nucl Med 34:1045, 1993.
17. Park CH, Kim SM, Zhang JJ, Intenzo CM, McEwan JR: Tc-99m MIBI brain SPECT in the diagnosis of recurrent glioma. Clin Nucl Med 19:57, 1994.
18. Basoglu T, Sahin M, Coskun C, et al: Technetium-99m-tetrofosmin uptake in malignant lung tumours. Eur J Nucl Med 22:687, 1995.
19. Nemec J, Nyvltova O, Preiningerova M, et al: Positive thyroid cancer scintigraphy using 99TCm-tetrofosmin (Myoview): A preliminary report. Nucl Med Commun 16:694, 1995.
20. Rambaldi PF, Mansi L, Procaccini E, Di Gregorio F, Del Vecchio E: Breast cancer detection with Tc-99m tetrofosmin. Clin Nucl Med 20:703, 1995.
21. Matsunari I, Kinuya S, Nishikawa T, et al: Technetium-99m tetrofosmin uptake in lung cancer: Comparison with thallium-201. Ann Nucl Med 10:143, 1996.
22. Mansi L, Rambaldi PF, Procaccini E, et al: Scintimammography with technetium-99m tetrofosmin in the diagnosis of breast cancer and lymph node metastases. Eur J Nucl Med 23:932, 1996.
23. Ishibashi M, Fujimoto K, Ohzono H, Meno S, Hayabuchi N: 99Tcm tetrofosmin uptake in mediastinal tumours. Br J Radiol 69:1134, 1996.
24. Aigner RM, Fueger GF, Zinke W, Sill H: 99Tcm-tetrofosmin scintigraphy in Hodgkin's disease. Nucl Med Commun 18:252, 1997.
25. Pineda J, Depiree LT, Robbins J, et al: Treating metastatic thyroid cancer. The Endocrinologist 3:433, 1993.
26. Dulgeroff A, Hershman J: Medical therapy for differentiated thyroid carcinoma. Endocrinol Rev 15:500, 1994.